Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Keith A. Yagaloff"'
Autor:
Keith A. Yagaloff, Xin-Jie Chu, Lucia Franco, Mitch Yeon, Grazyna Kurylko, Lida Qi, Li Chen, Adrian Wai-Hing Cheung, Karen Rowan, Joseph Swistok, Waleed Danho
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:1307-1311
A series of MT-II related cyclic peptides, based on potent but non-selective hMC4R agonist (Penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2)) was prepared in which His(6) residue was systematically substituted. Two of the most interesting peptides
Publikováno v:
Proceedings of the National Academy of Sciences. 97:12339-12344
Melanocortin-4 receptor (Mc4r)-null mice exhibit late-onset obesity. To determine whether aberrant metabolism contributes to the obesity, food consumption by Mc4r-null mice was restricted to (pair-fed to) that consumed by wild-type (WT) mice. Pair-fe
Publikováno v:
Journal of Receptors and Signal Transduction. 19:203-216
The recent cloning of the ob gene (leptin) has revolutionized our understanding of obesity and the underlying factors that govern weight homeostasis. There is growing evidence that long term food intake regulation is controlled by the central nervous
Autor:
Dennis Huszar, Donald J. Marsh, Gunther Hollopeter, Ralph Laufer, Richard D. Palmiter, Keith A. Yagaloff, Paul Burn, Stewart L. Fisher
Publikováno v:
Nature Genetics. 21:119-122
Mutations reducing the functional activity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and the melanocortin-4 receptor (Mc4r) all lead to obesity in mammals. Moreover, mutant mice that ectopically express either
Autor:
Gertjan van Dijk, Randy J. Seeley, Todd E. Thiele, Keith A. Yagaloff, Stewart L. Fisher, Paul Burn, Michael W. Schwartz
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 274(1), R248-R254. AMER PHYSIOLOGICAL SOC
Europe PubMed Central
Europe PubMed Central
Like leptin (OB protein), central infusion of the nonspecific melanocortin agonist MTII reduces food intake for relatively long periods of time (i.e., 12 h; W. Fan, B. A. Boston, R. A. Kesterson, V. J. Hruby, and R. D. Cone, Nature: 385: 165–168, 1
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 52:293-297
A series of essential fatty acids and fatty acid derivatives were evaluated for their ability to inhibit [3H] leukotriene B4 (LTB4) binding to pig neutrophil membranes. The fatty acids varied in chain length, extent of unsaturation, position of unsat
Autor:
Keith A. Yagaloff, Noal Cohen
Publikováno v:
Expert Opinion on Investigational Drugs. 3:13-22
Leukotriene B4 (LTB4) is a potent proinflammatory lipid mediator derived from arachidonic acid via the 5-lipoxygenase pathway. It is a powerful chemoattractant and activator of neutrophils and exhibits effects on other cell types as well. This eicosa
Autor:
Waleed Danho, Lida Qi, Xin-Jie Chu, Vijay Gore, Li Chen, Joseph Swistok, Adrian Wai-Hing Cheung, Grazyna Kurylko, David Joseph Bartkovitz, Keith A. Yagaloff
Publikováno v:
Bioorganicmedicinal chemistry letters. 15(24)
Two libraries of hMC4R agonists, X-Y-DPhe(7)-Arg(8)-2-Nal(9)-Z-NH(2) and X-Y-DPhe(7)-Arg(8)-Trp(9)-Z-NH(2), totaling 185 peptides were prepared using Irori radiofrequency tagging technology and Argonaut Quest 210 Synthesizer, where X stands for N-cap
Autor:
Lucia Franco, Joseph Swistok, Karen Rowan, David Joseph Bartkovitz, Li Chen, Adrian Wai-Hing Cheung, Lida Qi, Xin-Jie Chu, Mitch Yeon, Keith A. Yagaloff, Grazyna Kurylko, Waleed Danho
Publikováno v:
Bioorganicmedicinal chemistry letters. 15(22)
Linear pentapeptides (Penta-cis-Apc-DPhe-Arg-Trp-Gly-NH2) containing 1-amino-4-phenylcyclohexane-1-carboxylic acid (cis-Apc) and substituted Apc are potent hMC4R agonists and they are inactive or weakly active in hMC1R, hMC3R, and hMC5R agonist assay
Autor:
Waleed Danho, Grazyna Kurylko, Adrian Wai-Hing Cheung, Joseph Swistok, Xin-Jie Chu, Keith A. Yagaloff, Li Chen, Lucia Franco
Publikováno v:
Bioorganicmedicinal chemistry letters. 13(4)
A series of pentapeptides, based on hMC4R pentapeptide agonist (Bu-His(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2)), was prepared in which either DPhe(7) or Trp(9) residue was systematically substituted. A number of interesting DPhe surrogates (D-Thi, D-3